Beyond Bioenergetics: Moonlighting Functions of F 1 F O ‐ATPase From ATP Synthesis to an ATP‐Wasting Death Switch
Medicinal Research Reviews · 2026
DOI: 10.1002/med.70088 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2026. Verfasst von Salvatore Nesci. Beteiligte Einrichtung: Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Italy. Hauptthemen laut MEDLINE: Energy Metabolism, Adenosine Triphosphate, Proton-Translocating ATPases. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bologna, Università di Bologna.
Abstract (Originalsprache)
Mitochondrial F 1 F O ‐ATPase is classically viewed as the “splendid” rotary nanomachine that sustains life by converting the proton‐motive force (pmf) into ATP. Yet this same complex can adopt a second, context‐dependent function that links bioenergetics to cell fate. When oxygen becomes limiting during ischemia, stroke, hypoxia, or anoxia, respiratory chain activity declines, pmf collapses, and the enzyme reverses direction: ATP hydrolysis drives rotor turnover and pumps H + across the inner mitochondrial membrane to partially restore pmf. This reverse mode can be protective by preserving membrane potential and basic mitochondrial homeostasis, but it also imposes a severe energetic burden on the cell. A key determinant of whether F 1 F O ‐ATPase acts as an energy‐conserving or energy‐dissipating machine is the identity of the catalytic divalent cation. Under physiological conditions, Mg 2+ supports efficient, reversible ATP synthesis/hydrolysis. In pathology, mitochondrial Ca 2+ overload may replace Mg 2+ at catalytic sites, shifting catalysis toward ATP hydrolysis and promoting an ATP‐wasting state that triggers mitochondrial permeability transition pore (mPTP) formation and regulated cell death. Thus, ATP hydrolysis by F 1 F O ‐ATPase beyond regulation by pmf and inhibitory proteins such as IF1, cation cofactor selection emerges as a decisive switch that repurposes the enzyme from “enzyme of life” to “enzyme of death.” Here, this cofactor‐dependent reversibility is framed as a moonlighting role of F 1 F O ‐ATPase, integrating energy conversion with death signaling. Conceptual questions are outlined to resolve current debate and to exploit this switch for therapeutic insight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Italy.
ORCID-Profile: Salvatore Nesci
Förderung
- University of Bologna
- Università di Bologna
Zitieren
APA
Nesci, S. (2026). Beyond Bioenergetics: Moonlighting Functions of F 1 F O ‐ATPase From ATP Synthesis to an ATP‐Wasting Death Switch. Medicinal Research Reviews. https://doi.org/10.1002/med.70088
Vancouver
Nesci S. Beyond Bioenergetics: Moonlighting Functions of F 1 F O ‐ATPase From ATP Synthesis to an ATP‐Wasting Death Switch. Medicinal Research Reviews. 2026. doi:10.1002/med.70088
BibTeX
@article{Nesci2026,
author = {Nesci, Salvatore},
title = {Beyond Bioenergetics: Moonlighting Functions of F 1 F O ‐ATPase From ATP Synthesis to an ATP‐Wasting Death Switch},
journal = {Medicinal Research Reviews},
year = {2026},
doi = {10.1002/med.70088}
}
EUVIMED